학술논문
PRO104 DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
Document Type
Abstract
Author
Source
In Value in Health November 2019 22 Supplement 3:S860-S860
Subject
Language
ISSN
1098-3015